Could a gut antibiotic ease dementia? new study seeks answers
NCT ID NCT06718686
First seen Apr 15, 2026 · Last updated May 17, 2026 · Updated 4 times
Summary
This study tests a new form of the antibiotic rifaximin, which stays in the gut, to see if it can improve brain health in people with dementia. Researchers will check if changing gut bacteria affects inflammation and other markers. The study involves 20 adults aged 65 or older with mild to moderate Alzheimer's or vascular dementia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA ALZHEIMER TYPE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Richmond VA Medical Center
RECRUITINGRichmond, Virginia, 23249, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.